Literature DB >> 16601720

The paths around stem cell intellectual property.

Kenneth S Taymor1, Christopher Thomas Scott, Henry T Greely.   

Abstract

Can new approaches for deriving human stem cells circumnavigate existing patents that dominate embryonic stem cell intellectual property?

Entities:  

Mesh:

Year:  2006        PMID: 16601720     DOI: 10.1038/nbt0406-411

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  3 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

2.  Embryonic stem cell patents and human dignity.

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2007-03-29

3.  Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells.

Authors:  Xuejun H Parsons; Yang D Teng; Dennis A Moore; Evan Y Snyder
Journal:  Recent Pat Regen Med       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.